Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2086896Generated: October 25, 2026

2-Phenylimidazole → 2-[(2-Phenylimidazol-1-yl)methyl]-4-[3-(3,5-dichlorobenzoylamino)phenyl]-3-oxo-3,4-dihydropyrido[2,3-b]pyrazine

https://huagongshe.com/reaction/2086896

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-PhenylimidazoleHCID 69591—
ReactantSodium BicarbonateHCID 516892—
Reactant2-Bromomethyl-4-[3-(3,5-dichlorobenzoylamino)phenyl]-3-oxo-3,4-dihydropyrido[2,3-b]pyrazineHCID 22724526—
SolventDimethylformamideHCID 6228—
Product2-[(2-Phenylimidazol-1-yl)methyl]-4-[3-(3,5-dichlorobenzoylamino)phenyl]-3-oxo-3,4-dihydropyrido[2,3-b]pyrazineHCID 2272428216.2%

Reaction Steps

The solution of 2-bromomethyl-4-[3-(3,5-dichlorobenzoylamino)phenyl]-3-oxo-3,4-dihydropyrido[2,3-b]pyrazine (285 mg) and 2-phenylimidazole (734 mg) in N,N-dimethylformamide (30 ml) was stirred for 3 hours at 80° C. The mixture was poured into aqueous sodium hydrogencarbonate (150 ml) and extracted by ethyl acetate (150 mg). The organic layer was evaporated and chromatographed to obtain 2-[(2-phenylimidazol-1-yl)methyl]-4-[3-(3,5-dichlorobenzoylamino)phenyl]-3-oxo-3,4-dihydropyrido[2,3-b]pyrazine (52 mg) in brown powder form.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06727245B2
Source datasetuspto-grants-2004_04
ORD IDord-7b27107a0a724550910e6c17a2d7e74e
Source noteuspto-grants-2004_04